Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients. - Concepedia

Concepedia

Publication | Closed Access

Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.

65

Citations

0

References

1996

Year

Xiaoyan Qiu, Dan Lu, Jiemin Zhou, Junzhi Wang, Jingjing Yang, Jessica Hsueh

Abstract

Implantation of autologous fibroblast genetically modified to secrete human hFIX offers a simple, safe and effective approach to gene therapy of hemophilia B.